129 related articles for article (PubMed ID: 20446059)
1. Prognostic significance of clinical parameters and Epstein-Barr virus infection in non-endemic undifferentiated carcinoma of nasopharyngeal type: a Serbian report.
Terzic TT; Boricic MI; Pendjer IP; Ruzic Zecevic DT; Tomanovic NR; Brasanac DC; Boricic IV
Med Oncol; 2011 Dec; 28(4):1325-30. PubMed ID: 20446059
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-encoded small RNA 1 (EBER-1) could predict good prognosis in nasopharyngeal carcinoma.
Zeng Z; Fan S; Zhang X; Li S; Zhou M; Xiong W; Tan M; Zhang W; Li G
Clin Transl Oncol; 2016 Feb; 18(2):206-11. PubMed ID: 26260913
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-encoded RNAs as a survival predictor in nasopharyngeal carcinoma.
Ke K; Wang H; Fu S; Zhang Z; Duan L; Liu D; Ye J
Chin Med J (Engl); 2014; 127(2):294-9. PubMed ID: 24438619
[TBL] [Abstract][Full Text] [Related]
4. Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status.
Peng H; Chen L; Zhang Y; Guo R; Li WF; Mao YP; Tan LL; Sun Y; Zhang F; Liu LZ; Tian L; Lin AH; Ma J
Oncotarget; 2016 Apr; 7(17):24208-16. PubMed ID: 27008701
[TBL] [Abstract][Full Text] [Related]
5. Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a non-endemic area.
Alfieri S; Iacovelli NA; Marceglia S; Lasorsa I; Resteghini C; Taverna F; Mazzocchi A; Orlandi E; Guzzo M; Bianchi R; Fanti D; Pala L; Racca S; Dvir R; Quattrone P; Gloghini A; Volpi CC; Granata R; Bergamini C; Locati L; Licitra L; Bossi P
Oncotarget; 2017 Jul; 8(29):47780-47789. PubMed ID: 28562354
[TBL] [Abstract][Full Text] [Related]
6. [Undifferentiated Carcinoma of the Nasopharynx in Dakar, an Area Supposed to be Non-Endemic: about 13 Cases].
Gaye AM; Mouamba FG; Diemé MJ; Niang D; Thiam I; Dial CMM
Bull Soc Pathol Exot; 2018; 111(2):84-89. PubMed ID: 30789241
[TBL] [Abstract][Full Text] [Related]
7. Undifferentiated carcinoma of nasopharyngeal type (UCNT): a Swiss single-institutional experience during 1990-2005.
Sidler D; Thum P; Winterhalder R; Huber G; Haerle SK
Swiss Med Wkly; 2010 May; 140(19-20):273-9. PubMed ID: 19950040
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr Virus in Nasopharyngeal Carcinoma of Guatemalan and Brazilian Patients.
Rumayor Piña A; Dos Santos HT; Carlos R; Altemani A; de Almeida OP
Int J Surg Pathol; 2017 Jun; 25(4):304-309. PubMed ID: 27881609
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the Variability of Epstein-Barr Virus Genes in Nasopharyngeal Biopsies: Potential Predictors for Carcinoma Progression.
Banko AV; Lazarevic IB; Folic MM; Djukic VB; Cirkovic AM; Karalic DZ; Cupic MD; Jovanovic TP
PLoS One; 2016; 11(4):e0153498. PubMed ID: 27071030
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: A nationwide study in Finland.
Ruuskanen M; Irjala H; Minn H; Vahlberg T; Randen-Brady R; Hagström J; Syrjänen S; Leivo I
Head Neck; 2019 Feb; 41(2):349-357. PubMed ID: 30549170
[TBL] [Abstract][Full Text] [Related]
11. Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes.
Nicholls JM; Lee VH; Chan SK; Tsang KC; Choi CW; Kwong DL; Lam KO; Chan SY; Tong CC; So TH; Leung TW; Luk MY; Khong PL; Lee AW
Br J Cancer; 2019 Oct; 121(8):690-698. PubMed ID: 31527689
[TBL] [Abstract][Full Text] [Related]
12. [In situ hybridization in undifferentiated nasopharynx carcinoma in Tunisia. Report of 3 cases].
Baizig Nehla M; Hamouda B; Asma K; Farhat BA; Abderahmen L; Omrane BH; Ahmed el M
Tunis Med; 2001 Oct; 79(10):544-7. PubMed ID: 11910697
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of TROP2 in human nasopharyngeal carcinoma.
Guan GF; Zhang DJ; Wen LJ; Yu DJ; Zhao Y; Zhu L; Guo YY; Zheng Y
Int J Clin Exp Pathol; 2015; 8(9):10995-1004. PubMed ID: 26617817
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of oncogenic human papilloma virus and Epstein-Barr virus prevalence in Turkish nasopharyngeal cancer patients.
Tatlı Doğan H; Kılıçarslan A; Doğan M; Süngü N; Güler Tezel G; Güler G
Pathol Res Pract; 2016 Nov; 212(11):1021-1026. PubMed ID: 27640103
[TBL] [Abstract][Full Text] [Related]
15. Expression of Epstein-Barr-virus-encoded small nuclear RNA in nasopharyngeal carcinomas of Aegean Turkish patients.
Ertan Y; Hekimgil M; Karaarslan S; Soydan S
Virchows Arch; 2008 Apr; 452(4):411-4. PubMed ID: 18299891
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and relevance of EBV latency in nasopharyngeal carcinoma in Israel.
Bar-Sela G; Kuten A; Minkov I; Gov-Ari E; Ben-Izhak O
J Clin Pathol; 2004 Mar; 57(3):290-3. PubMed ID: 14990602
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Epstein-Barr Virus (EBV) and PD-L1 Expression in Nasopharyngeal Carcinoma Patients in a Non-Endemic Region.
Dias JM; Santana IVV; da Silva VD; Carvalho AL; Arantes LMRB
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233023
[TBL] [Abstract][Full Text] [Related]
18. The influence of human papillomavirus on nasopharyngeal carcinoma in Japan.
Kano M; Kondo S; Wakisaka N; Moriyama-Kita M; Nakanishi Y; Endo K; Murono S; Nakamura H; Yoshizaki T
Auris Nasus Larynx; 2017 Jun; 44(3):327-332. PubMed ID: 27499435
[TBL] [Abstract][Full Text] [Related]
19. Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma.
Ruuskanen M; Leivo I; Minn H; Vahlberg T; Haglund C; Hagström J; Irjala H
BMC Cancer; 2019 Jun; 19(1):624. PubMed ID: 31238894
[TBL] [Abstract][Full Text] [Related]
20. Sinonasal undifferentiated carcinoma and nasopharyngeal-type undifferentiated carcinoma: two clinically, biologically, and histopathologically distinct entities.
Jeng YM; Sung MT; Fang CL; Huang HY; Mao TL; Cheng W; Hsiao CH
Am J Surg Pathol; 2002 Mar; 26(3):371-6. PubMed ID: 11859210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
